3.1 million doses of AstraZeneca from the EU “did not rise”: Australian Prime Minister

Australian Prime Minister Scott Morrison opposed allegations that he criticized the European Union for delaying the arrival of the AstraZeneca vaccine on Tuesday.

At a press conference on Wednesday, he said he “briefly stated the fact” that 3.1 million doses of AstraZeneca vaccine had not arrived in Australia from the European Union (EU) by the end of March, as originally planned. ..

“3.1 million of the contracted vaccines we relied on in early January, when we set a set of goals, were not found in Australia,” Morrison said.

The federal government initially contracted for 3.8 million doses of the Oxford-AstraZeneca vaccine in September 2020. However, in early January, the government was said to receive 1.2 million of the original 3.8 million doses, 500,000 doses in February, and 700,000 doses in March. ..

However, the delivery was affected by a vaccine shortage in Europe, and AstraZeneca exported to Australia after European Commission President Ursula von der Leyen told Morrison that more time was needed to consider the proposal. Was told to reduce the number of approvals to 250,000.

Then, on March 3, the European Union refused to export 250,000 copies to Australia, German media reported. DW, EC-backed Italy failed to fulfill its EU-specific contract to provide 100 million doses of vaccine ordered between December and March, resulting in 250,000 AstraZeneca jabs. After blocking shipments.

Vaccine roadmap (pdf) Points out that the Australian Government’s investment in COVID-19 vaccine has exceeded $ 6 billion ($ 4.6 billion). This includes 53.8 million purchases of AstraZeneca vaccine. Most of it will take place in Australia. Approval According to the Therapeutic Goods Authority (TGA) for the Australian company CSL to manufacture the AstraZeneca vaccine.

The European Union is facing a scrutiny of its move with other countries to condemn the block of vaccine nationalism.

But the European Council Chair Charles Michel Said This was not the case for the reported Reuters at all. “We want to stop exporting the doses we ordered and pre-financed to other developed countries when we haven’t delivered what we promised,” Michelle said.

“The EU has never stopped exporting,” he said.

Epoch Times Photo
The laboratory technician oversees the large-scale production and supply of the Oxford University AstraZeneca COVID-19 vaccine at the Italian biomedical manufacturing facility in Anagni, Italy, on September 11, 2020. (Photo courtesy of VINCENZO PINTO / AFP, Getty Images)

Vaccine deployment will not be affected, Australian government says

On Wednesday, Professor Brendan Murphy assured Australia that these issues would not affect the deployment of the COVID-19 vaccine.

“I would like to reiterate that the vaccine is on track,” Murphy said.

“It is only the supply of vaccines that limits deployment, and obviously the first problem with vaccine supply is related to that 3.1 million doses of AstraZeneca, because there were no such doses. It really brought us back in the first few weeks. It comes from Pfizer’s international supply and the gradual increase in CSL, as there are doses of CSL that are starting to increase gradually. It’s a quantity, “he said.

The news of vaccine delays comes when Australia records the first case of a 44-year-old man who was hospitalized for a blood clot after an injection of AstraZeneca vaccine.

Professor Michael Kidd, Deputy Chief Health Officer of the Australian Ministry of Health, said interview With ABC, the incident was very worrisome. A TGA expert was examining the report.

Currently, 20 countries around the world have suspended or postponed the deployment of AstraZeneca vaccination due to concerns about the link between vaccines and blood clots in healthy people receiving jabs.

Posted on